Acelrx Pharmaceuticals (ACRX) Q2 2023 Earnings

10AugConfirmed
Nov 22
Q4 2022
Q1 2023
Q2 2023
-1.2
-0.93
-0.67
-0.4

Details

Expected EPS
-0.53
Actual EPS
-0.4
Surprise EPS
0.13
Surprise Percent
+24.53%

Description

Acelrx Pharmaceuticals (ACRX) has reported earnings of -0.4 per share for Q2 2023.

0 Comments

Share your thoughts